The efficacy of a novel, triple combination in the treatment of MM
Isatuximab for multiple myeloma - promising results and next steps
Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
CASTOR and POLLUX trial results for multiple myeloma reported at ASCO and EHA